In 2007, CVRx got money. In 2008, it will be looking to get clinical data. A start-up medical-device company based in Brooklyn Park, CVRx raised its fourth round of private equity financing, totaling $65 million, in May.
It also has launched a pivotal 300-patient clinical trial to establish the effectiveness of its Rheos system—a pacemaker-like device implanted under the skin on the upper chest with leads that snake to the carotid arteries in the neck. CVRx wants to offer a new treatment option for the millions of patients suffering from hypertension whose disease cannot be managed with medications. Yared had executive stints with Medtronic and GE Medical before becoming CVRx’s CEO in October 2006.
